EC Number |
Recommended Name |
Source Tissue |
Reference |
---|
1.4.3.4 | monoamine oxidase |
podocyte |
- |
655721 |
1.6.3.1 | NAD(P)H oxidase (H2O2-forming) |
podocyte |
- |
711090 |
2.3.1.B41 | protein-long-chain fatty-acyl-lysine deacylase (NAD+) |
podocyte |
- |
756973 |
2.3.1.B41 | protein-long-chain fatty-acyl-lysine deacylase (NAD+) |
podocyte |
a dramatic reduction in Sirt6 is detected in the podocytes in diabetic mice relative to those in control mice |
-, 756973 |
2.7.1.137 | phosphatidylinositol 3-kinase |
podocyte |
- |
738465, 760521 |
2.7.1.150 | 1-phosphatidylinositol-3-phosphate 5-kinase |
podocyte |
- |
738465 |
2.7.1.91 | sphingosine kinase |
podocyte |
podocyte cell line |
705438 |
3.4.11.7 | glutamyl aminopeptidase |
podocyte |
- |
683521 |
3.4.11.7 | glutamyl aminopeptidase |
podocyte |
developing |
665903 |
3.4.17.23 | angiotensin-converting enzyme 2 |
podocyte |
- |
680388 |
3.4.19.12 | ubiquitinyl hydrolase 1 |
podocyte |
cell culture, expression of UCH-L1 and the regulation of this expression in podocytes, overview |
709664 |
3.4.19.12 | ubiquitinyl hydrolase 1 |
podocyte |
expresses UCH-L1 and expression correlates with the differentiation status. In the cortex of normal biopsies, UCH-L1 is predominantly expressed in distal tubules, macula densa, and nerve fibres. A subset of human glomerulopathies associated with podocyte foot process effacement (membranous nephropathy, SLE class V, FSGS) de novo express UCH-L1 in podocyte cell bodies, nuclei, and processes |
699730 |
3.4.19.12 | ubiquitinyl hydrolase 1 |
podocyte |
the enzyme is found in tubular and parietal cells of the kidney and is expressed de novo in injured podocytes |
754564 |
3.4.19.12 | ubiquitinyl hydrolase 1 |
podocyte |
UCHL1 is expressed in podocytes of K256E-ACTN4pod+/UCHL1+/+ mice |
731353 |
3.4.21.46 | complement factor D |
podocyte |
- |
698194 |
3.4.22.27 | cathepsin S |
podocyte |
- |
753981 |
3.4.23.15 | renin |
podocyte |
podocytes express a functional intrinsic renin-angiotensin system characterized by neprilysin, aminopeptidase A, ACE2, and renin activities, which predominantly lead to angiotensin(1-7) and angiotensin(1-9) formation, as well as angiotensin II degradation |
677495 |
3.4.24.65 | macrophage elastase |
podocyte |
ICGN strain, small amounts during early pogression of renal disease, increasing amounts with progressing renal disease (immunohistochemistry) |
699886 |
3.4.24.87 | ADAMTS13 endopeptidase |
podocyte |
secretes the enzyme |
711809 |
4.4.1.5 | lactoylglutathione lyase |
podocyte |
- |
729179 |
6.3.2.11 | carnosine synthase |
podocyte |
- |
744004 |